DENTSPLY SIRONA (XRAY) director receives 179.449 RSUs at $0
DENTSPLY SIRONA (XRAY) filed a Form 4 for director Willie A. Deese.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DENTSPLY SIRONA (XRAY) filed a Form 4 for director Willie A. Deese. On 10/10/2025, 179.449 restricted stock units were acquired at $0 under code A as dividend equivalents on existing RSUs. After this entry, beneficial ownership is 57,546.558 shares, held directly. These dividend RSUs follow the same vesting schedule as the underlying awards, with each RSU converting to common stock on a 1:1 basis.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 179.449 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did XRAY report on Form 4?
Why were the XRAY RSUs acquired at $0?
What does code A mean in this XRAY Form 4?
How do the dividend RSUs vest for XRAY?
What is the reporting person's role at XRAY?
AI-generated analysis. How Rhea-AI works. Not financial advice.